Quick Answer
SINOVAC BIOTECH LTD reported R&D Expense of $344.51 million for fiscal year 2023.
SINOVAC BIOTECH LTD R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2023 | $344.51M | -22.1% |
| 2022 | $442.11M | +185.2% |
| 2021 | $155.04M | +218.0% |
| 2020 | $48.76M | +101.0% |
| 2019 | $24.25M | +10.7% |
| 2018 | $21.91M | +6.9% |
| 2017 | $20.49M | +62.0% |
| 2016 | $12.65M | +33.3% |
| 2015 | $9.49M | -13.2% |
| 2014 | $10.93M | +34.5% |
| 2013 | $8.13M | -52.3% |
| 2012 | $17.04M | +89.2% |
| 2011 | $9.01M | +5.9% |
| 2010 | $8.51M | +93.1% |
| 2009 | $4.41M | — |
- SINOVAC BIOTECH LTD showed a decrease of -22.1% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2023 period, SINOVAC BIOTECH LTD’s r&d expense has grown by 7719.9% (from $4.41 million to $344.51 million).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: